Schultz, Michael B.
Kane, Alice E.
Mitchell, Sarah J.
MacArthur, Michael R. http://orcid.org/0000-0003-3593-6995
Warner, Elisa http://orcid.org/0000-0001-6694-2701
Vogel, David S.
Mitchell, James R.
Howlett, Susan E. http://orcid.org/0000-0001-5351-6308
Bonkowski, Michael S.
Sinclair, David A. http://orcid.org/0000-0002-9936-436X
Article History
Received: 25 November 2019
Accepted: 16 August 2020
First Online: 15 September 2020
Change Date: 8 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: D.A.S. is a founder, equity owner, advisor to, director of, consultant to, investor in and/or inventor on patents licensed to Vium, Jupiter Orphan Therapeutics, Cohbar, Galilei Biosciences, GlaxoSmithKline, OvaScience, EMD Millipore, Wellomics, Inside Tracker, Caudalie, Bayer Crop Science, Longwood Fund, Zymo Research, Immetas, and EdenRoc Sciences (and affiliates Arc-Bio, Dovetail Genomics, Claret Bioscience, Revere Biosensors, UpRNA and MetroBiotech, Liberty Biosecurity); Life Biosciences (and affiliates Selphagy, Senolytic Therapeutics, Spotlight Biosciences, Animal Biosciences, Iduna, Continuum Biosciences, Jumpstart Fertility (an NAD booster company), and Lua Communications); Iduna is a cellular reprogramming company, partially owned by Life Biosciences. D.A.S sits on the board of directors of both companies. D.A.S. is an inventor on a patent application filed by Mayo Clinic and Harvard Medical School that has been licensed to Elysium Health; his personal share is directed to the Sinclair lab. For more information seeExternalRef removed. M.S.B. is a stockholder for MetroBiotech and Animal Biosciences, a division of Lifebiosciences. Other authors have no conflicts to declare.